G

M

GAGNIEU , Marie-Claude

Last name: GAGNIEU

First name: Marie-Claude

November 2016 (v1)

Journal article

Metadata-only

Maraviroc/raltegravir simplification strategy following 6 months of quadruple therapy with tenofovir/emtricitabine/maraviroc/raltegravir in treatment-naive HIV patients

Pradat, Pierre Durant, Jacques Brochier, Corinne

OBJECTIVE: We assessed the virological efficacy of a 6 month maraviroc/raltegravir simplification strategy following 6 months of quadruple therapy combining tenofovir disoproxil fumarate/emtricitabine with maraviroc/raltegravir. METHODS: HIV-1-infected naive patients were enrolled in an open label, single-arm, Phase 2 trial. All patients...

Uploaded on: December 4, 2022
December 2016 (v1)

Journal article

Metadata-only

Efficiency and Safety of an Early Dose Adjustment of Ribavirin in Patients Infected With Hepatitis C Underexposed to the Drug and Treated With Peginterferon Ribavirin

Loustaud-Ratti, Véronique Maynard, Marianne Thevenon, Sylvie

BACKGROUND: Ribavirin exposure after the first dose (D0AUC0-4h) \textgreater1755 mcg.h.L is predictive of sustained virological response (SVR) in patients with hepatitis C treated with peginterferon and ribavirin. The aim of this study was to test the benefit of ribavirin early dose adjustment based on this target in naive patients infected...

Uploaded on: December 4, 2022